Skip to main content

No Link Found Between COVID-19 Vaccination During Pregnancy and Spontaneous Abortion

Medically reviewed by Carmen Pope, BPharm. Last updated on May 15, 2025.

By Lori Solomon HealthDay Reporter

THURSDAY, May 15, 2025 -- There is no association between COVID-19 vaccination in pregnancy and spontaneous abortion, according to a study published online May 2 in Obstetrics & Gynecology.

Sangini S. Sheth, M.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined the association between COVID-19 vaccination and spontaneous abortion. Analysis included patients aged 16 to 49 years with singleton pregnancies, one or more prenatal visits, and continuous health plan enrollment. Those with spontaneous abortion (296; between 6 and less than 20 weeks of gestation) were matched with 592 live births between Jan. 19, 2021, and Oct. 27, 2021.

The researchers found that there was no association between spontaneous abortion and COVID-19 vaccination (adjusted odds ratio [aOR], 0.85; 95 percent confidence interval [CI], 0.56 to 1.30). Similarly, there was no association between spontaneous abortion and dose number versus no vaccine (one dose: aOR, 0.81; 95 percent CI, 0.39 to 1.70; two doses: aOR, 0.84; 95 percent CI, 0.51 to 1.38; vaccine manufacturer: Moderna aOR, 0.59 [95 percent CI, 0.29 to 1.19], Pfizer-BioNTech aOR, 0.97 [95 percent CI, 0.57 to 1.66]). Lastly, there was no association for vaccine exposure window of six weeks before spontaneous abortion or index date (aOR, 0.87; 95 percent CI, 0.53 to 1.44).

"This is a rigorously conducted study that continues to show that the COVID-19 vaccines are safe during pregnancy," Sheth said in a statement. "For women who are early in pregnancy or those who are thinking about getting pregnant, given the risks of COVID-19 disease, they should feel encouraged to go ahead and get vaccinated if they are not already."

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

AAP Updates Guidance on Evaluation, Treatment of Patent Ductus Arteriosus in Preemies

THURSDAY, May 15, 2025 -- In a clinical report published in the May issue of Pediatrics, the American Academy of Pediatrics presents updated guidance on the evaluation and...

RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization

TUESDAY, May 13, 2025 -- Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated hospitalization rates among...

Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults

FRIDAY, May 9, 2025 -- mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.